메뉴 건너뛰기
Fudan University Journal of Medical Sciences
Volumn 31, Issue 1, 2004, Pages
Radioprotective effect of amifostine in nasopharyngeal carcinoma
Author keywords

Amifostine; Nasopharyngeal carcinoma; Radiotherapy
Indexed keywords

BIOLOGICAL ORGANS; MEDICAL PROBLEMS; PATIENT MONITORING; TUMORS;
EID: 3242667215     PISSN: 16728467     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (5)
References (7)
  • 1
    • 0028969271 scopus 로고
    • Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)
    • Cox JD, Stetz J, Pajak TH. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys, 1995, 31(5):1341
    • (1995) Int J Radiat Oncol Biol Phys , vol.31 , Issue.5 , pp. 1341
    • Cox, J.D.1    Stetz, J.2    Pajak, T.H.3
  • 2
    • 0034332891 scopus 로고    scopus 로고
    • Has the outlook improved for amifostine as a clinical radioprotector?
    • Lindegaard JC, Grau C. Has the outlook improved for amifostine as a clinical radioprotector? Radiother Oncol, 2000, 57(2):113
    • (2000) Radiother Oncol , vol.57 , Issue.2 , pp. 113
    • Lindegaard, J.C.1    Grau, C.2
  • 3
    • 0029902007 scopus 로고    scopus 로고
    • Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: Results of a randomized trial in patients with ovarian cancer
    • Kemp G, Rose P, Lurain J, et al. Amifostine Pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized trial in patients with ovarian cancer. J Clin Oncol, 1996, 14:2101
    • (1996) J Clin Oncol , vol.14 , pp. 2101
    • Kemp, G.1    Rose, P.2    Lurain, J.3
  • 4
    • 0036126435 scopus 로고    scopus 로고
    • Intrarectal application of amifostine for the prevention of radiation-induced rectal injury
    • Ben JE, Han S, Tobi M, et al. Intrarectal application of amifostine for the prevention of radiation-induced rectal injury. Semin Radiat Oncol, 2002, 12(1 Suppl 1):81
    • (2002) Semin Radiat Oncol , vol.12 , Issue.1 SUPPL. 1 , pp. 81
    • Ben, J.E.1    Han, S.2    Tobi, M.3
  • 5
    • 0035889299 scopus 로고    scopus 로고
    • Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer
    • Antonadou D, Coliarakis N, Synodinou M, et al. Randomized phase III trial of radiation treatment +/- amifostine in patients with advanced-stage lung cancer. Int J Radiat Oncol Biol Phys, 2001, 51(4):915
    • (2001) Int J Radiat Oncol Biol Phys , vol.51 , Issue.4 , pp. 915
    • Antonadou, D.1    Coliarakis, N.2    Synodinou, M.3
  • 6
    • 0034305965 scopus 로고    scopus 로고
    • Randomized phase III trial of amifostine as a radioprotector in head and neck cancer
    • Brizel DM, Wasserman TH, Henke M, et al. Randomized phase III trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol, 2000, 18(19):3339
    • (2000) J Clin Oncol , vol.18 , Issue.19 , pp. 3339
    • Brizel, D.M.1    Wasserman, T.H.2    Henke, M.3
  • 7
    • 0036987232 scopus 로고    scopus 로고
    • Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma
    • Bourhis J, Rosine D. Radioprotective effect of amifostine in patients with head and neck squamous cell carcinoma. Semin Oncol, 2002, 29(6 suppl 19):61
    • (2002) Semin Oncol , vol.29 , Issue.6 SUPPL. 19 , pp. 61
    • Bourhis, J.1    Rosine, D.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.